查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451893

2024-2032 年按類別、應用（社區獲得性呼吸道感染、泌尿道感染、牙科等）、藥物來源、活性譜、藥物類型和地區分類的口服抗生素市場報告

Oral Antibiotics Market Report by Class, Application (Community-acquired Respiratory Tract Infections, Urinary Tract Infections, Dental and Others), Drug Origin, Spectrum of Activity, Drug Type, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球口服抗生素市場規模達到204.014億美元。展望未來， IMARC Group預計到2032年，市場規模將達到276.122億美元，2024-2032年複合年成長率（CAGR）為3.32%。傳染病的日益流行、老年人口的擴大、針對抗藥性細菌的有效治療的需求不斷增加，以及個人化醫療和基因組學的成長趨勢是推動市場的一些關鍵因素。

口服抗生素是主要用於抑制細菌生長或消除體內細菌的藥劑。它們通常透過口腔服用，並在廣泛的醫療應用中使用。口服抗生素治療的感染類型各不相同，包括皮膚、耳朵、喉嚨和泌尿道感染等常見疾病，以及某些類型的肺炎等更複雜的疾病。這些抗生素分為不同的類別，每種抗生素都有不同的作用機轉。一些常用的處方類別包括青黴素類、氟喹諾酮類、四環素類和大環內酯類。每一類針對不同類型的細菌，對特定細菌感染更有效。例如，青黴素廣泛用於治療鏈球菌感染，而氟喹諾酮類藥物則可用於對抗某些革蘭氏陰性細菌。因此，口服抗生素是現代醫療保健的關鍵要素，並被醫療保健專業人員廣泛使用，以成功治療多種細菌感染。

口服抗生素市場趨勢：

傳染病的日益普及以及公眾對這些疾病的可用治療方案的認知不斷提高，是支持市場成長的主要因素。此外，越來越多的老年人口更容易發生此類感染，這是推動市場成長的另一個主要因素。此外，抗生素管理計畫增加，旨在鼓勵抗生素的廣泛使用，減緩抗生素抗藥性的出現，並確保這些藥物的長期有效性。同時，日益嚴重的抗生素抗藥性問題迫使研究人員和製藥公司修改現有類別並開發能夠治療多重抗藥性細菌的新抗生素，從而加快產品採用率。此外，領先的製藥公司和研究機構正在藥物發現過程中利用人工智慧（AI）和機器學習（ML）來預測細菌抗藥性模式，了解藥物與細菌的相互作用，並加快新型抗生素的發現。與此一致的是，個人化醫療和基因組學的出現促進了市場的成長，其中個人化醫療和基因組學涉及透過考慮患者的基因組成等因素來為個別患者量身定做抗生素治療，以提高治療效果並最大限度地減少副作用。其他因素，包括對抗藥性細菌有效治療的需求不斷增加、醫療基礎設施的改善、新型口服抗生素的不斷推出以及對研發（R＆D）活動的​​大量投資，預計也將推動未來市場的成長年。

本報告回答的關鍵問題：

  • 迄今為止，全球口服抗生素市場表現如何，未來幾年將如何表現？
  • 全球口服抗生素市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球口服抗生素市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的口服抗生素市場？
  • 市場按類別分類是怎麼樣的？
  • 口服抗生素市場中哪一類最具吸引力？
  • 基於應用程式的市場區隔是什麼？
  • 口服抗生素市場中最具吸引力的應用是什麼？
  • 根據藥品來源分類的市場是怎麼樣的？
  • 口服抗生素市場上最具吸引力的藥源是哪一個？
  • 依活動範圍分類的市場是怎麼樣的？
  • 口服抗生素市場中最具吸引力的活動範圍是什麼？
  • 根據藥物類型分類的市場是怎麼樣的？
  • 口服抗生素市場上最具吸引力的藥物類型是什麼？
  • 全球口服抗生素市場競爭格局如何？
  • 全球口服抗生素市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球口服抗生素市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依類別

  • BETA內醯胺和BETA內醯胺酶抑制劑
    • 市場走向
    • 關鍵環節
      • 青黴素
      • 頭孢菌素
      • 其他
    • 市場預測
  • 奎諾酮類
    • 市場走向
    • 市場預測
  • 大環內酯
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 社區型呼吸道感染 (CARTI)
    • 市場走向
    • 關鍵環節
      • 上呼吸道感染 (URTI)
      • 下呼吸道感染 (LRTI)
    • 市場預測
  • 泌尿道感染 (UTI)
    • 市場走向
    • 市場預測
  • 牙科
    • 市場走向
    • 關鍵環節
      • 組合
      • 單一療法
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依藥物來源

  • 自然的
    • 市場走向
    • 市場預測
  • 半合成
    • 市場走向
    • 市場預測
  • 合成的
    • 市場走向
    • 市場預測

第 9 章：市場區隔：依活動範圍

  • 廣效抗生素
    • 市場走向
    • 市場預測
  • 窄譜抗生素
    • 市場走向
    • 市場預測

第 10 章：市場區隔：依藥物類型

  • 品牌化
    • 市場走向
    • 市場預測
  • 泛型
    • 市場走向
    • 市場預測

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 12 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Bayer AG
    • Cipla Inc
    • Gilead Sciences Inc
    • Janssen Inc. (Johnson & Johnson Services, Inc)
    • Pfizer Inc.
    • Roche Holding AG
    • Sun Pharmaceutical Industries Ltd
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A8355

The global oral antibiotics market size reached US$ 20,401.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 27,612.2 Million by 2032, exhibiting a growth rate (CAGR) of 3.32% during 2024-2032. The increasing prevalence of infectious diseases, expanding geriatric population, escalating demand for effective treatments against drug-resistant bacteria, and the growing trend of personalized medicine and genomics represent some of the key factors driving the market.

Oral antibiotics are pharmaceutical agents primarily prescribed to inhibit bacterial growth or eliminate bacteria from the body. They are usually taken by mouth and are utilized across a wide range of medical applications. The types of infections treated by oral antibiotics vary and include common ailments such as skin, ear, throat, and urinary tract infections and more complex conditions like certain types of pneumonia. These antibiotics are categorized into different classes, each with a distinct mechanism of action. Some commonly prescribed classes include penicillins, fluoroquinolones, tetracyclines, and macrolides. Each class targets different types of bacteria and is more effective for specific bacterial infections. For instance, penicillins are widely used for streptococcal infections, while fluoroquinolones may be chosen to combat certain gram-negative bacteria. As a result, oral antibiotics are a key element of modern healthcare and are widely prescribed by healthcare professionals to enable the successful treatment of numerous bacterial infections.

Oral Antibiotics Market Trends:

The increasing prevalence of infectious diseases and the rising public awareness about the available treatment options for these conditions represent the primary factors supporting market growth. Moreover, the expanding geriatric population that is more susceptible to developing such infections is another major factor fueling the market growth. In addition, there has been a rise in antibiotic stewardship programs aimed at encouraging the widespread use of antibiotics, slowing down the emergence of antibiotic resistance, and ensuring the prolonged effectiveness of these drugs. Along with this, the growing issue of antibiotic resistance has compelled researchers and pharmaceutical companies to modify existing classes and develop new antibiotics capable of treating multi-drug resistant bacteria, thereby accelerating the product adoption rate. Furthermore, the leading pharmaceutical companies and research institutes are leveraging artificial intelligence (AI) and machine learning (ML) in the drug discovery process to predict bacterial resistance patterns, understand drug-bacteria interactions, and expedite the discovery of novel antibiotics. In line with this, the emergence of personalized medicine and genomics, which involves tailoring antibiotic treatment to individual patients by considering factors such as their genetic makeup to enhance treatment effectiveness and minimize side effects, has catalyzed market growth. Other factors, including escalating demand for effective treatments against drug-resistant bacteria, improving healthcare infrastructure, the continual launch of novel oral antibiotics, and heavy investments in research and development (R&D) activities, are also anticipated to propel the market growth in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global oral antibiotics market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on the class, application, drug origin, spectrum of activity, and drug type.

Class Insights:

Beta Lactam and Beta Lactamase Inhibitors

Penicillin

Cephalosporin

Others

Quinolone

Macrolide

Others

The report has provided a detailed breakup and analysis of the oral antibiotics market based on the class. This includes beta lactam and beta lactamase inhibitors (penicillin, cephalosporin, and others), quinolone, macrolide, and others. According to the report, beta lactam and beta lactamase inhibitors represented the largest segment.

Application Insights:

Community-acquired Respiratory Tract Infections (CARTIs)

Upper Respiratory Tract Infections (URTI)

Lower Respiratory Tract Infections (LRTIs)

Urinary Tract Infections (UTIs)

Dental

Combination

Monotherapies

Others

A detailed breakup and analysis of the oral antibiotics market based on the application has also been provided in the report. This includes community-acquired respiratory tract infections (upper respiratory tract infections (URTI) and lower respiratory tract infections (LRTIs)), urinary tract infections (UTIs), dental (combination and monotherapies), and others. According to the report, urinary tract infections (UTIs) accounted for the largest market share.

Drug Origin Insights:

Natural

Semisynthetic

Synthetic

The report has provided a detailed breakup and analysis of the oral antibiotics market based on the drug origin. This includes natural, semisynthetic, and synthetic. According to the report, synthetic represented the largest segment.

Spectrum of Activity Insights:

Broad-spectrum Antibiotic

Narrow Spectrum Antibiotic

A detailed breakup and analysis of the oral antibiotics market based on the spectrum of activity has also been provided in the report. This includes broad-spectrum antibiotic and narrow spectrum antibiotic.

Drug Type Insights:

Branded

Generics

The report has provided a detailed breakup and analysis of the oral antibiotics market based on the drug type. This includes branded and generics.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia-Pacific was the largest market for oral antibiotics. Some of the factors driving the Asia-Pacific oral antibiotics market included its aging population, growing burden of infectious diseases, high healthcare expenditure, the presence of various key players, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global oral antibiotics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bayer AG, Cipla Inc., Gilead Sciences Inc., Janssen Inc. (Johnson & Johnson Services, Inc.), Pfizer Inc., Roche Holding AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global oral antibiotics market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global oral antibiotics market?
  • What is the impact of each driver, restraint, and opportunity on the global oral antibiotics market?
  • What are the key regional markets?
  • Which countries represent the most attractive oral antibiotics market?
  • What is the breakup of the market based on the class?
  • Which is the most attractive class in the oral antibiotics market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the oral antibiotics market?
  • What is the breakup of the market based on the drug origin?
  • Which is the most attractive drug origin in the oral antibiotics market?
  • What is the breakup of the market based on the spectrum of activity?
  • Which is the most attractive spectrum of activity in the oral antibiotics market?
  • What is the breakup of the market based on the drug type?
  • Which is the most attractive drug type in the oral antibiotics market?
  • What is the competitive structure of the global oral antibiotics market?
  • Who are the key players/companies in the global oral antibiotics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oral Antibiotics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Class

  • 6.1 Beta Lactam and Beta Lactamase Inhibitors
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Penicillin
      • 6.1.2.2 Cephalosporin
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Quinolone
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Macrolide
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Community-acquired Respiratory Tract Infections (CARTIs)
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Upper Respiratory Tract Infections (URTI)
      • 7.1.2.2 Lower Respiratory Tract Infections (LRTIs)
    • 7.1.3 Market Forecast
  • 7.2 Urinary Tract Infections (UTIs)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Dental
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Combination
      • 7.3.2.2 Monotherapies
    • 7.3.3 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Drug Origin

  • 8.1 Natural
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Semisynthetic
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Synthetic
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Spectrum of Activity

  • 9.1 Broad-spectrum Antibiotic
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Narrow Spectrum Antibiotic
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Drug Type

  • 10.1 Branded
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Generics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Bayer AG
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Cipla Inc
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Gilead Sciences Inc
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Janssen Inc. (Johnson & Johnson Services, Inc)
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Pfizer Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Roche Holding AG
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Sun Pharmaceutical Industries Ltd
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Teva Pharmaceutical Industries Ltd.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Oral Antibiotics Market: Major Drivers and Challenges
  • Figure 2: Global: Oral Antibiotics Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Oral Antibiotics Market: Breakup by Class (in %), 2023
  • Figure 5: Global: Oral Antibiotics Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Oral Antibiotics Market: Breakup by Drug Origin (in %), 2023
  • Figure 7: Global: Oral Antibiotics Market: Breakup by Spectrum of Activity (in %), 2023
  • Figure 8: Global: Oral Antibiotics Market: Breakup by Drug Type (in %), 2023
  • Figure 9: Global: Oral Antibiotics Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Oral Antibiotics (Beta Lactam and Beta Lactamase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Oral Antibiotics (Beta Lactam and Beta Lactamase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Oral Antibiotics (Quinolone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Oral Antibiotics (Quinolone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Oral Antibiotics (Macrolide) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Oral Antibiotics (Macrolide) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Oral Antibiotics (Other Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Oral Antibiotics (Other Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Oral Antibiotics (Community-acquired Respiratory Tract Infections (CARTIs)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Oral Antibiotics (Community-acquired Respiratory Tract Infections (CARTIs)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Oral Antibiotics (Urinary Tract Infections (UTIs)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Oral Antibiotics (Urinary Tract Infections (UTIs)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Oral Antibiotics (Dental) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Oral Antibiotics (Dental) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Oral Antibiotics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Oral Antibiotics (Other Applications) Market Forecast: Sales Value (in Million US$), 2018-2023
  • Figure 26: Global: Oral Antibiotics (Natural) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Oral Antibiotics (Natural) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Oral Antibiotics (Semisynthetic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Oral Antibiotics (Semisynthetic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Oral Antibiotics (Synthetic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Oral Antibiotics (Synthetic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Oral Antibiotics (Broad-spectrum Antibiotic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Oral Antibiotics (Broad-spectrum Antibiotic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Oral Antibiotics (Narrow Spectrum Antibiotic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Oral Antibiotics (Narrow Spectrum Antibiotic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Oral Antibiotics (Branded) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Oral Antibiotics (Branded) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Oral Antibiotics (Generics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Oral Antibiotics (Generics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Oral Antibiotics Market: Sales Value (in Million US$),2018 & 2023
  • Figure 41: North America: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Oral Antibiotics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Oral Antibiotics Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Oral Antibiotics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Oral Antibiotics Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Oral Antibiotics Industry: Value Chain Analysis
  • Figure 91: Global: Oral Antibiotics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oral Antibiotics Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Oral Antibiotics Market Forecast: Breakup by Class (in Million US$), 2024-2032
  • Table 3: Global: Oral Antibiotics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Oral Antibiotics Market Forecast: Breakup by Drug Origin (in Million US$), 2024-2032
  • Table 5: Global: Oral Antibiotics Market Forecast: Breakup by Spectrum of Activity (in Million US$), 2024-2032
  • Table 6: Global: Oral Antibiotics Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 7: Global: Oral Antibiotics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Oral Antibiotics Market: Competitive Structure
  • Table 9: Global: Oral Antibiotics Market: Key Players